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We haveexamined DNAadductformation inHL-60cellsand human bonemarrow treatedwitheitherhydroquinone
orp-benzoquinone andhavefoundthatthesetreatmentsproducethesameDNAadductinbothcelltypes. TheDNAad-





reactedwithp-benzoquinone, ggeting thatcellular environment modifies DNAadduct productionbyp-benzoquinone.
These studiesdemonstratethatDNAadductformation occursinhuman bonemarrowtreatedwith benzenemetabolites










can be used as adosimeter ofexposure.
Initial benzenemetabolismoccurs intheliverwith formation
ofbenzene oxide by P-450 oxidation followed by spontaneous
conversion to phenol. This primary metabolite is further oxi-
dized tohydroquinone (HQ)andcatechol (6). Thesemetabolites




The PI-nuclease-enhanced "P-postlabeling procedure has
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Resultsand Discussion
Identification ofBenzene-DNA Adducts
Reaction ofpBQ with DNA produced three major DNA ad-
ducts asdetectedby 32P-postlabeling (Fig. 1). Adduct2 wasthe
FIGURE 1. Autoradiogram of32P-postlabeled calfthymus DNA reacted with
p-benzoquinone(pBQ). ThereactionofpBQwithDNA, 32P-postlabeling,
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FIGURE 4. Autoradiogram of32P-postlabeled DNA. (A) DNA isolated form
bone marrow treated with250yMofp-benzoquinone (pBQ) for2 hr. (B) Co-
chromatography of32P-postlabeled DNA from A with 32P-postlabeled DNA
from HL-60 cells treated with 250, /AM ofpBQ for 2 hr.
Detection ofDNA Adducts in Human
Bone Marrow
Bone marrow is the target tissue for leukemogenic effects
benzene in humans. For our study wehave obtained bone mar-
row samples frompatients undergoingjointreplacement opera-
tions. Treatment ofbone marrow with 250 1.M ofpBQ for 2 hr
produced asingle DNA adduct in bone marrow cells (Fig. 4A).
Co-chromatography studies of32P-postlabeled DNA from bone
FIGURE 5. The induction of DNA adducts in HL-60 cells treated with p-
benzoquinone(pBQ) (A) andhydroquinone(HQ) (0)andhumanbone mar-
row treated with various doses ofpBQ (-) and HQ (0). The doses ofeach
agent areexpressed as theproductoftheconcentration andtreatmenttime.
The slopes ofthese curves were estimated by linear regression analysis.
marrow treated with pBQ with 32P-postlabeled DNA from
HL-60cellstreatedwith250itMofpBQfor2 hrsamplesclearly
showthattheadductformedinbone marrowcellsis identical to
that formed in HL-60 cells. (Fig. 4B).
Comparisonofthe extentofDNAadductformation inHL-60
cells and bone marrow after HQ andpBQ treatment was made
byanalyzingtheslopesofthedose-response curves(Fig. 5). For
HQ treatmentthe slopes were 19.8 x 10-4forHL-60 and5.16 x
10-4 for bone marrow, where as forpBQ treatment the slopes
were21.6 x 1i-3 and 3.14 x 1O-3 forHL-60and bone marrow,
respectively. Comparison ofthese values shows that HQ is ap-
proximately 4- to 5-foldandpBQ is approximately 7- to 8-fold
moreeffective atadductformation inHL-60cellscompared to
bone marrow. Apossibleexplanationforthereducedbinding in
bone marrow is that this tissue contains both erythroid and
myeloidcellsandonly themyeloidcellshavethecapacity to ac-
tivateHQ. ThesestudiesdemonstratethatHL-60cells are agood
model for the activation and binding ofbenzene metabolites in
the myeloid cells ofhuman bone marrow.
Comparison ofAdducts Formed in DNA
and in Cells
DNA isolated from HL-60 cells treated with 2501iM ofHQ
for 8 hr was 32P-postlabeled andco-chromatographed with 32p_
postlabeled DNA reacted with pBQ. Figure 6 shows that the
cellularadduct as indicateddid notcorrespond to any ofthe ma-
jor adducts formed in DNA.
Conclusion
The DNA adducts formed in HL-60 cells and bone marrow
treatedeitherwithpBQ orwithHQ are identical. These results
areconsistentwiththerequirement forHQ tobeenzymatically
oxidizedtopBQ to form DNA adducts. The mechanism for ac-
tivation of HQ is probably via MPO (8). The DNA adduct
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correspond to any of the (3'-hydroxy)-benzetheno adducts
formed inDNAreactedwithpBQ. Thisresultsuggeststhateither
chromatin structure orenzymatic processes within the cell are
influencing DNA adduct formation by HQ andpBQ.
Our studies have identified a DNA adduct formed by the
benzene metabolites hydroquinone andpBQinhumanbonemar-
rowandsuggestthatDNAadductformationbythesemetabolites
may be involved in benzene-induced leukemogenesis. The ap-
plication oftheP1-enhanced 32P-postlabeling procedure should
allow fordetectionofbenzene-DNAadductsinpopulations ex-
posedtobenzeneeitheroccupationally orfromtobaccosmoke.
However, these results also indicate thatcells containing perox-
idase activity suchas neutrophils wouldbetheappropriate cell
type formonitoring theeffectsofbenzeneexposure, ratherthan
lymphocytes, which do not contain peroxidase activity.
This manuscript was presentedas aposteratthe Conference onBiomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona, Hawaii, 26
October-I November 1991.
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